Results 271 to 280 of about 251,978 (341)

Dupilumab Treatment in Pemphigus: A Report of Three Cases and Literature Review

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Pemphigus vulgaris (PV) and foliaceus (PF) are rare autoimmune blistering diseases traditionally treated with systemic corticosteroids, immunosuppressants, intravenous immunoglobulins, and rituximab. Nonetheless, a subset of patients remains refractory or has contraindications to these conventional therapies.
José Javier Mateos Rico   +5 more
wiley   +1 more source

Low frequency of N-methyl-D-aspartate receptor autoimmunity in tick-borne encephalitis. [PDF]

open access: yesPLoS One
Morén J   +8 more
europepmc   +1 more source

Never say never

open access: yes
Journal of Hospital Medicine, EarlyView.
Gurpreet Dhaliwal   +4 more
wiley   +1 more source

Concurrent Psoriasis and Dermatomyositis: Retrospective Analysis and Literature Review

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Psoriasis (PsO) and dermatomyositis (DM) are both autoimmune‐mediated, inflammatory conditions. The concurrence of PsO and DM is rare, and literature on their relationship remains limited. Additionally, cutaneous DM can be challenging to clinically diagnosis, often presenting with psoriasiform clinical features.
Emily R. Gordon   +5 more
wiley   +1 more source

Forsythiaside A Alleviates Kidney Injury and Intestinal Epithelium Dysfunction in IgA Nephropathy by Inhibiting TLR4/NF‐κB Signaling

open access: yesThe Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT IgA nephropathy (IgAN), the most common form of glomerulonephritis, is a major and growing public health issue. It results from intestinal barrier dysfunction that leads to mesangial deposition of pathogenic galactose‐deficient IgA1 (Gd‐IgA1) and renal inflammation.
Meng‐Si Li, Kai Liu
wiley   +1 more source

Interleukin-6 levels and their haplotypes are associated with serological autoantibodies status and clinical activity in rheumatoid arthritis. [PDF]

open access: yesFront Immunol
Flores-Castro MN   +7 more
europepmc   +1 more source

Deleterious Effects of a GAD65 Monoclonal Autoantibody on Islet Function. [PDF]

open access: yesDiabetes
Hampe CS   +5 more
europepmc   +1 more source

Nipocalimab‐aahu (IMAAVY) for Generalized Myasthenia Gravis: Redefining Treatment With FcRn Inhibition

open access: yesMedicine Advances, EarlyView.
FDA approval of IMAAVY (nipocalimab) marks a major advancement in the management of generalized myasthenia gravis (gMG). Clinical trial data showed significant improvements in MG‐ADL scores, especially in AChR‐positive patients, while also highlighting its favorable safety profile, potential for subcutaneous self‐administration, and greater ...
Muhammad Affan Abid   +3 more
wiley   +1 more source

Natural autoantibodies and their functional therapeutic roles in intravenous immunoglobulin. [PDF]

open access: yesFront Aging
Danieli MG   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy